Casdin Capital, LLC 13D and 13G filings for Tango Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-13 9:34 pm Sale | 2022-12-31 | 13G | Tango Therapeutics, Inc. TNGX | Casdin Capital, LLC | 0 0.000% | -5,487,910 (Position Closed) | Filing |
| 2021-08-19 4:59 pm Purchase | 2021-08-10 | 13G | Tango Therapeutics, Inc. TNGX | Casdin Capital, LLC | 5,487,910 6.300% | 5,487,910 (New Position) | Filing |